Stevens-Johnson syndrome (SJS) progresses fast. The entire sequence, from the first vague flu-like symptoms to widespread skin blistering and detachment, typically unfolds over roughly one to five days. That speed is what makes the condition so dangerous: by the time the skin starts peeling, the reaction is already a medical emergency requiring burn-unit level care.
The Prodromal Phase: Days 1 to 3
Before any visible skin changes appear, SJS announces itself with symptoms that look a lot like a common illness. One to three days before a rash develops, you may notice fever, a sore mouth and throat, fatigue, and burning or gritty-feeling eyes. These symptoms are easy to dismiss, especially if you recently started a new medication (the most common trigger). Nothing about this early stage looks like a skin emergency, which is part of what makes SJS so difficult to catch early.
This prodromal window is the closest thing to a warning period. If you’ve recently begun a medication known to carry SJS risk and you develop an unexplained fever with mouth soreness and eye irritation, that combination deserves immediate medical attention rather than a wait-and-see approach.
How the Skin Lesions Develop
After the prodromal phase, skin involvement begins and escalates quickly. The rash typically starts as flat, reddish or purplish spots on the face and trunk, then spreads outward toward the arms and legs. Within hours to a day or two, these spots darken, merge, and develop blisters. The skin becomes tender to the touch, and the outer layer begins to loosen and peel away, similar to a severe burn.
The extent of skin detachment is what separates SJS from its more severe form, toxic epidermal necrolysis (TEN). SJS involves less than 10% of the body’s surface area. When detachment reaches 10 to 30%, it’s classified as SJS/TEN overlap. Above 30%, it’s TEN. The same underlying process drives all three, and SJS can progress into TEN if the reaction isn’t halted. This escalation can happen within days.
Mucosal Involvement Starts Early
The moist, mucous membrane surfaces of the body are often affected before or alongside the skin rash. The mouth, lips, throat, eyes, and genital area can develop painful blisters and raw, eroded patches. Eye involvement is particularly concerning because it can cause lasting damage to the cornea and other structures if not treated aggressively from the start.
Mouth and throat erosions can become severe enough to make eating, drinking, and swallowing extremely painful. This creates a secondary problem: dehydration and nutritional decline compound the body’s stress at a time when it’s already under enormous strain. Many patients require IV fluids and nutritional support during the acute phase for this reason.
Peak Severity and Systemic Risks
SJS typically reaches its worst point within four to six days of the first skin symptoms appearing. During this peak, the body is essentially dealing with an open wound across a significant portion of its surface. The loss of the skin barrier creates the same dangers faced by severe burn patients: fluid loss, temperature instability, and vulnerability to infection.
Sepsis is the most common life-threatening complication during the acute phase. Bacteria can enter through the damaged skin, and the immune system is already in a state of crisis. Organ failure involving the lungs, liver, or kidneys can follow. Death from SJS and TEN is primarily caused by sepsis and multi-organ failure, with gastrointestinal bleeding and blood clots in the lungs as additional contributing risks.
Doctors use a scoring system called SCORTEN to estimate mortality risk based on seven factors: age over 40, presence of cancer, elevated heart rate, extent of initial skin detachment, and certain blood chemistry markers. Depending on how many of these risk factors are present, predicted mortality ranges from 3.2% to as high as 90%. Even at the milder end of the spectrum, SJS carries real danger.
Why Early Treatment Changes Outcomes
The speed of SJS progression means that treatment delays have measurable consequences. A multicenter study across 15 regional burn centers found that patients transferred to a burn unit within seven days of disease onset had significantly higher survival rates than those transferred later. Delayed referral was associated with longer hospital stays and increased mortality.
The first and most critical step in treatment is identifying and stopping the triggering medication. Every hour the offending drug remains in the system allows the immune reaction to continue expanding. Once the drug is stopped, the reaction doesn’t halt immediately, but it does begin to slow. Supportive care in a burn unit or intensive care setting focuses on wound management, infection prevention, pain control, fluid replacement, and protecting the eyes and other mucosal surfaces.
How Long Recovery Takes
Once the reaction has been stopped and the skin detachment peaks, new skin gradually regrows from the edges and base of the wounds. For SJS with limited involvement, this re-epithelialization process generally takes two to three weeks. More extensive cases, particularly those reaching TEN severity, can require four weeks or longer in the hospital, with skin healing continuing after discharge.
The acute skin healing, however, is only part of the recovery picture. Long-term complications are common and can persist for months or years. Eye problems, including chronic dryness, scarring, and light sensitivity, affect a significant proportion of survivors. Skin may remain discolored or scarred. Mouth and genital tissues can develop adhesions or chronic sensitivity. Many survivors also experience lasting fatigue and psychological effects, including anxiety about taking medications in the future.
Recognizing the Timeline at a Glance
- Days 1 to 3: Fever, sore throat, burning eyes, fatigue (prodromal phase)
- Days 2 to 5: Red or purple spots appear, rapidly progressing to blisters and skin peeling; mucosal surfaces become raw and painful
- Days 4 to 8: Peak severity, with maximum skin detachment and highest risk of infection and organ complications
- Weeks 2 to 4: Skin begins to regrow if the reaction has been controlled and supportive care is in place
- Weeks to months: Ongoing recovery from eye, skin, and mucosal damage
The entire arc from first symptom to peak crisis can be as short as four or five days. That compressed timeline is what makes recognizing early warning signs so important, especially in anyone who has recently started a new medication.

